Neisseria meningitidis carriage rate, antibiotic susceptibility profile, and associated factors among prisoners at Jimma zonal correction facility in Jimma Town, Southwestern Ethiopia: a cross-sectional study.
Antibiotic
Carriage
Meningitides
Pharyngeal
Prisoner
Serogroup
Susceptibility
Journal
Tropical medicine and health
ISSN: 1348-8945
Titre abrégé: Trop Med Health
Pays: Japan
ID NLM: 101215093
Informations de publication
Date de publication:
16 Sep 2022
16 Sep 2022
Historique:
received:
11
06
2022
accepted:
07
09
2022
entrez:
16
9
2022
pubmed:
17
9
2022
medline:
17
9
2022
Statut:
epublish
Résumé
Neisseria meningitidis causes severe life-threatening meningococcal disease with a case fatality rate of 10-15% even with proper treatment. In Ethiopia, particularly in our study area, inadequate information is found on meningococcal disease. So, this study aimed to assess N. meningitidis carriage rate, antibiotic susceptibility profile, and associated factors among prisoners in Jimma Town, Southwestern Ethiopia. A cross-sectional study was conducted in Jimma town, Southwest Ethiopia, from May to October 2019. A stratified sampling technique was used and proportional allocation was done. A total of 550 oropharyngeal swabs were collected, processed, isolated, and identified N. meningitidis using standard microbiological techniques. Antibiotics susceptibility test was done for isolates using the disk diffusion method. Data on demographic and associated factors for carriage were collected using a structured questionnaire. Data were summarized using frequency, percentage, graph, and table. A logistic regression model was used to see the association between the dependent and independent variables. Variables with a p-value < 0.25 during bivariate analysis were included in multivariate analysis to identify factors significantly associated with the meningococcal carriage and, a p-value < 0.05 was considered statistically significant. Out of the 550 study participants, 76(13.8%) with (CI: 7.20-18.20) were found carriers of N meningitidis. The predominant isolates were non-serogroupable 26(34.2%) and serogroup W/Y 22(28.9%), respectively. N. meningitidis isolates showed highest sensitivity to chloramphenicol 74(97.4%). Meningococcal carriage rate was significantly associated with being age group of 16-20 years; having respiratory symptoms within 3 months and active cigarette smoking within 3 months. The majority of participants harbor most of the serogroups responsible for invasive cases of meningococcal disease. Respiratory symptoms, active cigarette smoking, and age group of 16-20 years increased the risk of N. meningitidis pharyngeal carriage rate. This study suggests providing better health education to control respiratory symptoms, smoking, and providing antibiotic prophylaxis for prisoners.
Sections du résumé
BACKGROUND
BACKGROUND
Neisseria meningitidis causes severe life-threatening meningococcal disease with a case fatality rate of 10-15% even with proper treatment. In Ethiopia, particularly in our study area, inadequate information is found on meningococcal disease. So, this study aimed to assess N. meningitidis carriage rate, antibiotic susceptibility profile, and associated factors among prisoners in Jimma Town, Southwestern Ethiopia.
METHODS
METHODS
A cross-sectional study was conducted in Jimma town, Southwest Ethiopia, from May to October 2019. A stratified sampling technique was used and proportional allocation was done. A total of 550 oropharyngeal swabs were collected, processed, isolated, and identified N. meningitidis using standard microbiological techniques. Antibiotics susceptibility test was done for isolates using the disk diffusion method. Data on demographic and associated factors for carriage were collected using a structured questionnaire. Data were summarized using frequency, percentage, graph, and table. A logistic regression model was used to see the association between the dependent and independent variables. Variables with a p-value < 0.25 during bivariate analysis were included in multivariate analysis to identify factors significantly associated with the meningococcal carriage and, a p-value < 0.05 was considered statistically significant.
RESULT
RESULTS
Out of the 550 study participants, 76(13.8%) with (CI: 7.20-18.20) were found carriers of N meningitidis. The predominant isolates were non-serogroupable 26(34.2%) and serogroup W/Y 22(28.9%), respectively. N. meningitidis isolates showed highest sensitivity to chloramphenicol 74(97.4%). Meningococcal carriage rate was significantly associated with being age group of 16-20 years; having respiratory symptoms within 3 months and active cigarette smoking within 3 months.
CONCLUSIONS
CONCLUSIONS
The majority of participants harbor most of the serogroups responsible for invasive cases of meningococcal disease. Respiratory symptoms, active cigarette smoking, and age group of 16-20 years increased the risk of N. meningitidis pharyngeal carriage rate. This study suggests providing better health education to control respiratory symptoms, smoking, and providing antibiotic prophylaxis for prisoners.
Identifiants
pubmed: 36114580
doi: 10.1186/s41182-022-00462-z
pii: 10.1186/s41182-022-00462-z
pmc: PMC9479249
doi:
Types de publication
Journal Article
Langues
eng
Pagination
67Informations de copyright
© 2022. The Author(s).
Références
Adv Exp Med Biol. 2015;836:19-28
pubmed: 25310944
Scand J Infect Dis. 2010;42(1):61-4
pubmed: 19883157
Vaccine. 2016 Nov 21;34(48):5855-5862
pubmed: 27780631
Malays J Pathol. 2007 Dec;29(2):91-4
pubmed: 19108400
PLoS One. 2018 Jun 11;13(6):e0198772
pubmed: 29889859
PLoS One. 2017 Oct 26;12(10):e0187207
pubmed: 29073269
Vaccine. 2009 Jun 24;27 Suppl 2:B64-70
pubmed: 19464092
J Infect. 2015 Jul;71(1):43-52
pubmed: 25709085
Emerg Infect Dis. 2006 Jun;12(6):950-7
pubmed: 16707051
Antimicrob Agents Chemother. 2009 Apr;53(4):1561-6
pubmed: 19188396
Int J Infect Dis. 2018 Aug;73:109-117
pubmed: 29997031
Int J Infect Dis. 2016 Jun;47:65-70
pubmed: 26612675
J Infect. 2018 Feb;76(2):140-148
pubmed: 29197599
J Infect Dis. 2017 Nov 27;216(9):1130-1140
pubmed: 28968661
Emerg Infect Dis. 2016 Jan;22(1):75-8
pubmed: 26689450
Yonsei Med J. 2012 Jul 1;53(4):742-7
pubmed: 22665340
BMC Infect Dis. 2016 Nov 4;16(1):639
pubmed: 27814682
Adv Exp Med Biol. 2017;955:29-37
pubmed: 27739025
PLoS One. 2018 Jul 18;13(7):e0200067
pubmed: 30020952
Vaccine. 2014 Sep 29;32(43):5677-80
pubmed: 25148776
Braz J Infect Dis. 2017 Nov - Dec;21(6):587-595
pubmed: 28711456
J Med Microbiol. 2004 Sep;53(Pt 9):821-832
pubmed: 15314188
Euro Surveill. 2015 Jul 16;20(28):
pubmed: 26212140
Pediatr Infect Dis J. 2015 Nov;34(11):1267-9
pubmed: 26222062
Emerg Infect Dis. 2017 Jun;23(6):1009-1011
pubmed: 28518025
Rev Panam Salud Publica. 2017 Dec 20;41:e118
pubmed: 31391828
Int J Infect Dis. 2016 Jun;47:60-4
pubmed: 27062987
Methods Mol Med. 2001;67:293-311
pubmed: 21337152